The Korean Society of Ginseng   Report issue

Academic/Hospital Phase 4
Founded: Seoul Korea, Republic of (1975)

Organization Overview

First Clinical Trial
2007
NCT00911768
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

The Korean Society of Ginseng

Active Ingredients

Drugs in Phase 4 Trials (1)

ginseng (6 trials)

Drugs in Other Trials (3)

fiber (1 trial)

ginsenoside (1 trial)

starch (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cryopyrin-Associated Periodic Syndromes (Phase 4)

Essential Hypertension (Phase 2)

Hypersensitivity (Phase 4)

Hypertension (Phase 2)

Xerostomia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 4